|
⚲
|
| Keyboard |
| Neuro Line Partners LP
✚
|
|
|---|---|
| CIK # | 0001723842 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001723842] | |
| 4 | [0001723842] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-12-21 | Other | 383,411 | ||
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-12-14 | Sell | 876 | $81.13 | 71,070 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-12-14 | Sell | 16,949 | $80.35 | 1,361,852 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-12-11 | Sell | 46,799 | $80.05 | 3,746,260 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-06-30 | Sell | 45,145 | $24.01 | 1,083,931 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-06-30 | Sell | 200 | $24.34 | 4,868 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-06-29 | Sell | 20,771 | $24.50 | 508,890 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-06-29 | Sell | 61,807 | $23.84 | 1,473,479 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-06-26 | Sell | 13,604 | $24.67 | 335,611 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-06-26 | Sell | 108,473 | $23.84 | 2,585,996 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-06-23 | Sell | 3,247 | $26.19 | 85,039 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-06-23 | Sell | 16,777 | $25.69 | 431,001 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-06-22 | Sell | 65,373 | $24.66 | 1,612,098 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-06-22 | Sell | 24,683 | $25.12 | 620,037 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-06-19 | Sell | 82,481 | $24.20 | 1,996,040 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2020-06-19 | Sell | 62,439 | $25.00 | 1,560,975 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2019-03-25 | Other | 158,764 | ||
|
Denali Therapeutics Inc DNLI
Series A-2 Convertible Preferred Stock · derivative
|
2017-12-12 | Conversion | 128,200 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Series B-1 Convertible Preferred Stock · derivative
|
2017-12-12 | Conversion | 240,000 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Series A-2 Convertible Preferred Stock · derivative
|
2017-12-12 | Conversion | 2,500,000 | $0.00 | |
| showing 20 of 30 most recent transactions | |||||